comorbidity

shutterstock_135966185

Introduction

Comorbidity, or the co-occurrence of two distinct medical conditions, is a common phrase in both physical and mental health. Whilst the term was originally conceived to describe medical phenomena, the term was adopted by psychiatry in the description of more than one clinical presentation occurring simultaneously. However, its use in psychiatry is not without controversy. 

What we know already

Large-scale prevalence data can seemingly tell us much about the high rate of comorbidity in mental health. Data from US National Comorbidity Survey, for example, suggested that, of those reporting mental health difficulties (across a 12-month prevalence), only 55% carried a single psychiatric diagnosis.

One important area of recent research concerns the rates of comorbidity of physical and mental health difficulties, particularly in the area of chronic health conditions. Mental Elf blogs have reported that people with schizophrenia are significantly more likely to die from heart disease and cancer; while the National Schizophrenia Audit calls for improved monitoring of physical health in people with schizophrenia. We know that depression and anxiety are more common when a person has a chronic health problem, and this comorbidity leads to poorer clinical and quality of life outcomes. This has led to an increase in interventions targeting the psychological consequences of chronic ill health.

Areas of uncertainty

The controversy in psychiatric comorbidity is the issues of mutual exclusivity. We are not able to conclude as to whether ‘comorbid’ psychiatric diagnoses are separate clinical entities, or multiple features of the same underlying cause. This has led to much criticism of the term ‘psychiatric comorbidity’.

Furthermore, certain diagnostic labels, such as personality disorders, attract particular scrutiny, due to their high levels of comorbidity with other mental health diagnoses. Similarly, people often meet the criteria for more than one personality disorder. This again creates uncertainty as to the precise nature of the condition, or conditions, being diagnosed.

What’s in the pipeline?

The recent publication of the Diagnostic and Statistic Manual (DSM)-5 seemingly retains the notion that multiple distinct clinical diagnoses exist, thus maintaining the argument for psychiatric comorbidity. Alternative conceptualisations have been suggested, along dimensional models, such as ‘anxious-misery’, ‘externalising’ and ‘fear-based’ dimensions. However, these were not adopted in the DSM-5.

As our understanding of mental health conditions continues to improve, so too hopefully will our understanding of comorbidity, and its relevance to psychological and psychiatric phenomena.

References

First, M. B. (2005). Mutually exclusive versus co-occurring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology, 38, 206-210. [Abstract]

Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry, 62, 617-627. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK. [Full text]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our comorbidity Blogs

Physical activity and schizophrenia: how much exercise do people do?

photo-1473663065522-33361623fa27

Joanne Wallace summarises a novel systematic review that actually quantifies the amount of physical activity done by people with schizophrenia.

[read the full story...]

CBT for Autism Spectrum Disorders and comorbid mental illness

angry-1576878_6401

Alix Dixon presents a recent systematic review on the effectiveness of CBT for autism spectrum disorders and comorbid anxiety or depression.

[read the full story...]

Annual health checks may reduce emergency hospital admissions for preventable conditions

4410796175_de11f80117_b

Pauline Heslop summarises a UK primary care study that shows how emergency hospital admissions for preventable conditions can be reduced in people with learning disabilities who receive annual health checks.

[read the full story...]

Depression and coronary heart disease: reasons to remain UPBEAT-UK

7389091466_b428f08970_k

Kirsten Lawson summarises the UPBEAT-UK programme of research into the relationship between coronary heart disease and depression and anxiety in primary care patients.

[read the full story...]

Integrated care for the physical health of people with severe mental illness: no easy answers

5043141711_aa13421867_b

Liz Hughes summarises a recent rapid review on integrated care to address the physical health needs of people with severe mental illness.

[read the full story...]

Treatment for depression in traumatic brain injury: Cochrane find no evidence for non-pharmacological interventions

2961565820_3d59b7bdfb_b

Eleanor Kennedy summarises a recent Cochrane systematic review, which finds no evidence to support the use of non-pharmacological interventions for depression in traumatic brain injury.

[read the full story...]

Pharmacotherapy for smoking cessation in severe mental illness

photo-1429035429336-ad854ea8a720

Andrew Jones reports on a recent systematic review and network meta-analysis of the efficacy and tolerability of pharmacotherapy for smoking cessation in severe mental illness, which finds a promising but low quality result for bupropion and varenicline.

[read the full story...]

Searching for solutions: a new brief intervention for comorbid substance misuse in acute psychiatric inpatients

8686574743_2b808fd439_k

Ian Hamilton presents the findings of a recent pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric inpatient settings.

[read the full story...]

Personality disorders, IAPT treatment and recovery from depression and anxiety

372736671_ba70deee47_o

Mark Smith reviews a recent prospective cohort study, which considers the impact of comorbid personality problems on response to IAPT (Improving Access to Psychological Therapies) treatment for depression and anxiety.

[read the full story...]